Glaucia Maria Machado-Santelli

Dr. Glaucia Maria Machado-Santelli

orcid

Research Focus & Metrics

Academic Career Length

51Years (1976-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2014 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
ENEvandro Luís Niero
Evandro Luís Niero
BRBianca Rocha-Sales
Bianca Rocha-Sales
CLCamila Lauand
Camila Lauand
BCBeatriz Araujo Cortez
Beatriz Araujo Cortez
MSMarcelo Medina de Souza
Marcelo Medina de Souza
GMGlaucia Maria Machado-Santelli
Glaucia Maria Machado-Santelli
Some cancers like melanoma and pancreatic and ovarian cancers, for example, commonly display resistance to chemotherapy, and this is the major obstacle to a better prognosis of patients. Frequently, literature presents studies in monolayer cell cultures, 3D cell cultures or in vivo studies, but rarely the same work compares results of drug resistance in different models. Several of these works are presented in this review and show that usually cells in 3D culture are more resistant to drugs than monolayer cultured cells due to different mechanisms. Searching for new strategies to sensitize different tumors to chemotherapy, many methods have been studied to understand the mechanisms whereby cancer cells acquire drug resistance. These methods have been strongly advanced along the years and therapies using different drugs have been increasingly proposed to induce cell death in resistant cells of different cancers. Recently, cancer stem cells (CSCs) have been extensively studied because they would be the only cells capable of sustaining tumorigenesis. It is believed that the resistance of CSCs to currently used chemotherapeutics is a major contributing factor in cancer recurrence and later metastasis development. This review aims to appraise the experimental progress in the study of acquired drug resistance of cancer cells in different models as well as to understand the role of CSCs as the major contributing factor in cancer recurrence and metastasis development, describing how CSCs can be identified and isolated.

23 May 2013 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
ENEvandro Luís de Oliveira Niero
Evandro Luís de Oliveira Niero
GMGlaucia Maria Machado-Santelli
Glaucia Maria Machado-Santelli
Anticancer activities of cinnamic acid derivatives include induction of apoptosis by irreversible DNA damage leading to cell death. The present work aimed to compare the cytotoxic and genotoxic potential of cinnamic acid in human melanoma cell line (HT-144) and human melanocyte cell line derived from blue nevus (NGM). Viability assay showed that the IC50 for HT-144 cells was 2.4 mM, while NGM cells were more resistant to the treatment. The growth inhibition was probably associated with DNA damage leading to DNA synthesis inhibition, as shown by BrdU incorporation assay, induction of nuclear aberrations and then apoptosis. The frequency of cell death caused by cinnamic acid was higher in HT-144 cells. Activated-caspase 3 staining showed apoptosis after 24 hours of treatment with cinnamic acid 3.2 mM in HT-144 cells, but not in NGM. We observed microtubules disorganization after cinnamic acid exposure, but this event and cell death seem to be independent according to M30 and tubulin labeling. The frequency of micronucleated HT-144 cells was higher after treatment with cinnamic acid (0.4 and 3.2 mM) when compared to the controls. Cinnamic acid 3.2 mM also increased the frequency of micronucleated NGM cells indicating genotoxic activity of the compound, but the effects were milder. Binucleation and multinucleation counting showed similar results. We conclude that cinnamic acid has effective antiproliferative activity against melanoma cells. However, the increased frequency of micronucleation in NGM cells warrants the possibility of genotoxicity and needs further investigation.

1 June 2011 in Journal of Medicinal Food
Verified
Journal Article
Closed access
VZVivian Zague
Vivian Zague
VFVanessa Freitas
Vanessa Freitas
MRMarina da Costa Rosa
Marina da Costa Rosa
GCGeórgia Álvares de Castro
Geórgia Álvares de Castro
RJRuy Gastaldoni Jaeger
Ruy Gastaldoni Jaeger
GMGlaucia Maria Machado-Santelli
Glaucia Maria Machado-Santelli
The effect of daily ingestion of collagen hydrolysate (CH) on skin extracellular matrix proteins was investigated. Four-week-old male Wistar rats were fed a modified AIN-93 diet containing 12% casein as the reference group or CH as the treatment group. A control group was established in which animals were fed a non–protein-modified AIN-93 diet. The diets were administered continuously for 4 weeks when six fresh skin samples from each group were assembled and subjected to extraction of protein. Type I and IV collagens were studied by immunoblot, and activities of matrix metalloproteinase (MMP) 2 and 9 were assessed by zymography. The relative amount of type I and IV collagens was significantly (P < .05) increased after CH intake compared with the reference diet group (casein). Moreover, CH uptake significantly decreased both proenzyme and active forms of MMP2 compared with casein and control groups (P < .05). In contrast, CH ingestion did not influence on MMP9 activity. These results suggest that CH may reduce aging-related changes of the extracellular matrix by stimulating anabolic processes in skin tissue.

10 March 2008 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
VFVanessa Freitas
Vanessa Freitas
MRMarisa Rangel
Marisa Rangel
LBLetícia F. Bisson
Letícia F. Bisson
RJRuy Gastaldoni Jaeger
Ruy Gastaldoni Jaeger
GMGlaucia Maria Machado-Santelli
Glaucia Maria Machado-Santelli

1 August 2004 in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
Verified
Journal Article
Closed access
ECE.M.M Cerqueira
E.M.M Cerqueira
IFIsaac Suzart Gomes Filho
Isaac Suzart Gomes Filho
STS Trindade
S Trindade
MLM.A Lopes
M.A Lopes
JPJ.S Passos
J.S Passos
GMGlaucia Maria Machado-Santelli
Glaucia Maria Machado-Santelli

1 January 2013 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
VFVanessa Freitas
Vanessa Freitas
Jonatas Bussador do AmaralJonatas Bussador do Amaral
Jonatas Bussador do Amaral
TSThaiomara A Silva
Thaiomara A Silva
ESEmerson S Santos
Emerson S Santos
FMFlávia R Mangone
Flávia R Mangone
GMGlaucia Maria Machado-Santelli
Glaucia Maria Machado-Santelli
ADAMTS-1 (a disintegrin and metalloprotease with thrombospondin motifs) is a member of the ADAMTS family of metalloproteases. Here, we investigated mRNA and protein levels of ADAMTS-1 in normal and neoplastic tissues using qPCR, immunohistochemistry and immunoblot analyses, and we addressed the role of ADAMTS-1 in regulating migration, invasion and invadopodia formation in breast tumor cell lines.